Wednesday, February 10, 2010, 11:52AM AEST - The Australian Stockmarket closes in 4 hours and 13 minutes.
To create a watchlist or portfolio of shares, Register

SCOLR Pharma Inc. (DDD)

 8:00AM AEST: 0.58 USD  Down 0.02 (3.33%)  
 MORE ON DDD 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 SCOLR PHARMA INC (AMEX:DDD) Delayed quote dataEdit
Last Trade:0.58 USD
Trade Time: 8:00AM AEST
Change:Down 0.02 (3.33%)
Prev Close:0.60
Open:0.59
Bid:N/A
Ask:N/A
1y Target Est:6.96
Day's Range:0.50 - 0.61
52wk Range:0.25 - 0.85
Volume:76,574
Avg Vol (3m):50,543.5
Market Cap:23.84M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add DDD to Portfolio   Download Data

 HEADLINES 
•SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Tue, Jan 5)
•SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Dec 16)
•SCOLR Pharma, Inc. Licenses Dietary Supplements
PR Newswire (Wed, Dec 2)
•SCOLR PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
EDGAR Online (Tue, Dec 1)
•SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards
PR Newswire (Tue, Dec 1)
•SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Thu, Nov 26)
•SCOLR PHARMA, INC. Financials
EDGAR Online Financials (Sat, Nov 14)
•SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
EDGAR Online (Mon, Nov 9)
•SCOLR PHARMA, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Nov 7)
•SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Tue, Nov 3)
More Headlines for DDD...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.17
EPS Est (in 2 years) (Dec-10) :-0.10
Avg Rec (current)*:N/A
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
SCOLR Pharma, Inc., a pharmaceutical company, develops and formulates prescription, over-the-counter, and nutritional products. The company uses its controlled delivery technology platform and develops water soluble and insoluble drugs, as well as...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices